Status:
COMPLETED
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization
Lead Sponsor:
University of Bern
Collaborating Sponsors:
University of Zurich
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Context: Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy b...
Detailed Description
Design: Randomized controlled, observer-blind trial comparing sirolimus-eluting stents with paclitaxel-eluting stents Patients: 1012 patients undergoing percutaneous coronary intervention. The two gr...
Eligibility Criteria
Inclusion
- Patients with either stable angina or an acute coronary syndrome were eligible to participate if they had at least one lesion with stenosis of at least 50 percent in a vessel with a reference diameter between 2.25 and 4.00 mm that was suitable for stent implantation.
Exclusion
- Allergy to antiplatelet drugs, heparin, stainless steel, contrast agents, sirolimus, or paclitaxel; participation in another coronary-device study; and terminal illness.
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
1012 Patients enrolled
Trial Details
Trial ID
NCT00297661
Start Date
April 1 2003
Last Update
October 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bern
Bern, Switzerland, 3010